Literature DB >> 17297586

Delayed humoral immunity in a patient with severe tick-borne encephalitis after complete active vaccination.

I Kleiter1, W Jilg, U Bogdahn, A Steinbrecher.   

Abstract

Tick-borne encephalitis virus (TBEV) is a common cause of viral encephalitis in parts of Central and Eastern Europe. Active immunization results in a high rate of seroconversion and is the most effective measure of decreasing the incidence of tick-borne encephalitis (TBE). Currently, booster vaccinations are recommended every 3 years after completion of primary immunization. However, titers of neutralizing antibodies decline with time after vaccination and with age and thus may be insufficient to protect from disease in the elderly. We report on a 54-year-old patient who had received his last booster vaccination 3 years before developing a severe TBE with delayed induction and longterm persistence of anti-TBEV-IgM-antibodies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17297586     DOI: 10.1007/s15010-006-6614-2

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  11 in total

1.  Chimeric tick-borne encephalitis/dengue virus is attenuated in Ixodes scapularis ticks and Aedes aegypti mosquitoes.

Authors:  Amber R Engel; Dana N Mitzel; Christopher T Hanson; James B Wolfinbarger; Marshall E Bloom; Alexander G Pletnev
Journal:  Vector Borne Zoonotic Dis       Date:  2010-12-13       Impact factor: 2.133

Review 2.  Tick-borne encephalitis: A review of epidemiology, clinical characteristics, and management.

Authors:  Petra Bogovic; Franc Strle
Journal:  World J Clin Cases       Date:  2015-05-16       Impact factor: 1.337

3.  Evaluation of the Langat/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteers.

Authors:  Peter F Wright; Sharon Ankrah; Susan E Henderson; Anna P Durbin; Jim Speicher; Stephen S Whitehead; Brian R Murphy; Alexander G Pletnev
Journal:  Vaccine       Date:  2008-01-04       Impact factor: 3.641

4.  May early intervention with high dose intravenous immunoglobulin pose a potentially successful treatment for severe cases of tick-borne encephalitis?

Authors:  Daniel Růžek; Gerhard Dobler; Hans Helmut Niller
Journal:  BMC Infect Dis       Date:  2013-07-03       Impact factor: 3.090

5.  Autonomic and peripheral nervous system function in acute tick-borne encephalitis.

Authors:  Bernhard Neumann; Wilhelm Schulte-Mattler; Sophie Brix; Peter Pöschl; Wolfgang Jilg; Ulrich Bogdahn; Andreas Steinbrecher; Ingo Kleiter
Journal:  Brain Behav       Date:  2016-05-05       Impact factor: 2.708

6.  Analysis of Multiple Risk Factors for Seronegative Rate of Anti-Tick-Borne Encephalitis Virus Immunization in Human Serum.

Authors:  Marta Janik; Sylwia Płaczkowska; Mieczysław Woźniak; Iwona Bil-Lula
Journal:  Medicina (Kaunas)       Date:  2020-05-20       Impact factor: 2.430

7.  Tick-borne Encephalitis Vaccine Failures: A 10-year Retrospective Study Supporting the Rationale for Adding an Extra Priming Dose in Individuals Starting at Age 50 Years.

Authors:  Karin E Hansson; Anja Rosdahl; Mona Insulander; Sirkka Vene; Lars Lindquist; Sara Gredmark-Russ; Helena H Askling
Journal:  Clin Infect Dis       Date:  2020-01-02       Impact factor: 9.079

8.  Patients with breakthrough tick-borne encephalitis suffer a more severe clinical course and display extensive magnetic resonance imaging changes.

Authors:  J N Wagner; M Sonnberger; A Troescher; I Krehan; A Hauser; J Panholzer; T J von Oertzen
Journal:  Eur J Neurol       Date:  2020-05-19       Impact factor: 6.089

9.  Low Virus-Specific IgG Antibodies in Adverse Clinical Course and Outcome of Tick-Borne Encephalitis.

Authors:  Petra Bogovič; Stanka Lotrič-Furlan; Tatjana Avšič-Županc; Miša Korva; Lara Lusa; Klemen Strle; Franc Strle
Journal:  Microorganisms       Date:  2021-02-07

10.  Upregulated Intrathecal Expression of VEGF-A and Long Lasting Global Upregulation of Proinflammatory Immune Mediators in Vaccine Breakthrough Tick-Borne Encephalitis.

Authors:  Miša Pavletič; Misa Korva; Nataša Knap; Petra Bogovič; Lara Lusa; Klemen Strle; Mirijam Nahtigal Klevišar; Tomaž Vovko; Janez Tomažič; Stanka Lotrič-Furlan; Franc Strle; Tatjana Avšič-Županc
Journal:  Front Cell Infect Microbiol       Date:  2021-07-01       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.